TABLE 2.
Clinical characteristics of patients with different clinical outcomes of HBV infection
| Variableb | Patient groupa
|
|||
|---|---|---|---|---|
| ASC | CHB | LC | HCC | |
| Male/female | 67/33 | 56/44 | 72/28 | 87/13 |
| Age (yrs) | 34.87 ± 12.5 | 36.75 ± 12.02 | 54.9 ± 12.69 | 55.79 ± 12.39 |
| HBV viral load (log10 copies/ml) | 4.42 ± 1.72 | 4.7 ± 1.77 | 3.68 ± 0.89 | 3.64 ± 0.65 |
| HBV pgRNA (log10 copies/ml) | 4.32 ± 2.36 | 4.41 ± 2.51 | 3.22 ± 2.13 | 3.14 ± 2.12 |
| HBsAg (IU/ml) | 7,393.32 ± 16,302.77 | 6,157.9 ± 11,583.95 | 1,831.56 ± 6,005.84 | 1,276.72 ± 1,697.07 |
| HBeAg (S/CO) | 251.15 ± 537.47 | 207.48 ± 485.05 | 52.39 ± 215.95 | 9.15 ± 77.28 |
a
ASC, asymptomatic hepatitis B virus carrier; CHB, chronic hepatitis B; LC, liver cirrhosis; HCC, hepatocellular carcinoma.
b
pgRNA, pregenomic RNA; HBsAg, hepatitis B virus surface antigen; HBeAg, hepatitis B virus e antigen; S/CO, specimen/cutoff ratio.